📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Diamines & Chemicals Q3 FY26: Net Loss Widens to ₹192.55 Lakhs as Revenue Drops 56% YoY
Diamines & Chemicals Limited reported a significant downturn in its Q3 FY26 results, with standalone revenue falling 56.4% YoY to ₹763.57 Lakhs. The company recorded a net loss of ₹192.55 Lakhs for the quarter, a sharp increase from the ₹15.34 Lakhs loss in the previous year's corresponding quarter. For the nine-month period, the company reported a total loss of ₹901.97 Lakhs compared to a profit of ₹287.07 Lakhs in the prior year. The decline is primarily attributed to poor performance in the Specialty Chemicals segment, which saw its segment results turn into a loss.
Key Highlights
Standalone Revenue from Operations fell to ₹763.57 Lakhs in Q3 FY26 from ₹1,751.41 Lakhs in Q3 FY25.
Net loss for the nine months ended Dec 31, 2025, stood at ₹901.97 Lakhs compared to a profit of ₹287.07 Lakhs in the previous year.
Specialty Chemicals segment loss before tax and finance costs was ₹290.20 Lakhs for the quarter.
Total expenses for the quarter were ₹1,139.19 Lakhs, significantly exceeding the total income of ₹835.63 Lakhs.
The company made a provision of ₹4.62 Lakhs towards the impact of new Labour Codes effective from November 2025.
💼 Action for Investors
The sharp decline in revenue and transition to significant losses indicate severe operational headwinds in the specialty chemicals sector. Investors should remain cautious and wait for signs of margin recovery or improved demand before considering any fresh investments.
Diamines & Chemicals Reports Q3 FY26 Net Loss of ₹1.93 Cr as Revenue Drops 56% YoY
Diamines & Chemicals Limited reported a significantly weak performance for the quarter ended December 31, 2025, posting a standalone net loss of ₹192.55 Lakhs compared to a profit of ₹157.50 Lakhs in the same quarter last year. Revenue from operations plummeted by over 56% YoY to ₹763.87 Lakhs, reflecting severe pressure in its core Specialty Chemicals segment. For the nine-month period ending December 2025, the company has accumulated a net loss of ₹901.97 Lakhs, a sharp reversal from the ₹287.07 Lakhs profit recorded in the previous year's corresponding period. The board also reviewed and approved a revised Related Party Policy during the meeting.
Key Highlights
Revenue from operations fell 56.4% YoY to ₹763.87 Lakhs in Q3 FY26 from ₹1,751.41 Lakhs in Q3 FY25.
Standalone net loss for the quarter stood at ₹192.55 Lakhs versus a net profit of ₹157.50 Lakhs in the prior year period.
Specialty Chemicals segment recorded a loss of ₹290.20 Lakhs before tax and finance costs during the quarter.
Nine-month (9M FY26) revenue declined to ₹2,917.05 Lakhs from ₹5,349.75 Lakhs in 9M FY25.
The company made a provision of ₹4.62 Lakhs towards the impact of new Labour Codes effective from November 2025.
💼 Action for Investors
The sharp decline in revenue and transition to significant losses indicate serious operational or market headwinds for the company's specialty chemicals business. Investors should remain cautious and wait for signs of margin stabilization or a recovery in demand before considering any fresh positions.
Diamines & Chemicals Gets GPCB Approval for Product Mix Amendment to Boost Production Capacity
Diamines & Chemicals Limited has received a Consolidated Consent & Authorization (CC&A) amendment from the Gujarat Pollution Control Board (GPCB) on January 21, 2026. This regulatory approval allows the company to modify its product mix and set up new industrial activities within its existing manufacturing unit in Vadodara. The management expects this move to facilitate the production of new items and contribute to an overall increase in total production capacity. The license is valid until September 30, 2027, providing a clear operational runway for the planned expansion.
Key Highlights
Received CC&A Amendment from Gujarat Pollution Control Board (GPCB) on January 21, 2026
Approval enables setting up of new industrial plant/activities within the existing manufacturing unit
The amendment allows for a revised product mix, leading to an increase in total production capacity
The regulatory license (Order AWH-151692) is valid for a period ending September 30, 2027
💼 Action for Investors
Investors should view this as a positive step toward volume growth and monitor the company's timeline for the commencement of new product manufacturing.